secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001104659-23-091383
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aziyo Q2 net sales $10.3M, net loss $10.6M; bone matrix recall drives $3M revenue reversal
--------------------------------------------------------------------------------

- Net sales $10.3M, down from $12.6M YoY; recall reversal of $3.0M of Q2 revenue.
- Gross margin 9.5% vs 38.8% prior year; recall cut gross profit by $5.0M and margin by 35%.
- Net loss $10.6M ($0.65 per share) vs $9.4M ($0.69 per share) YoY; cash $9.3M at June 30.
- Negotiating multiple LOIs to divest Orthopedic business; SimpliDerm up 32% YoY.
- CanGaroo RM 510(k) resubmission on track; working with FDA/CDC on viable bone matrix recall.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923091383/0001104659-23-091383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465923091383/tm2323741d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-091383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer